Lamotrigine Tablet
Product Images NDC 68788-7544

7 FDA label images from Preferred Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 68788-7544). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)
Chemical structure of Lamotrigine, showing its molecular framework with chlorine atoms and amine groups clearly depicted as part of its chemical composition.*
FDA Label Image

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)
A Kaplan-Meier failure probability curve over time in weeks, comparing Lamotrigine and Placebo. The y-axis shows failure probability (%) and the x-axis shows time in weeks. The graph includes censored data points marked, illustrating differences in failure rates between Lamotrigine and Placebo groups during the study period.*
FDA Label Image

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)
A line graph showing failure probability (%) over time in weeks, comparing two groups labeled 'Lamotrigine' and 'Placebo.' The graph includes censored data markers and shows increasing failure probability for both groups over approximately 75 weeks, with the placebo group exhibiting a higher failure probability than the lamotrigine group throughout the timeline.*
FDA Label Image

Image (Fe2785fe E8f4 4861 9511 88ef16b7232b 740 1)

FDA Label Image

Image (03f59daf B60e 46d1 B121 6a39361ee4f3 789 2)

Image (03f59daf B60e 46d1 B121 6a39361ee4f3 789 2)
Illustration showing four Lamotrigine tablets in different strengths and shapes. Depicted are 25 mg white oval tablets imprinted with U U 111, 100 mg white triangular tablets imprinted with U U 112, 150 mg white triangular tablets imprinted with U U 113, and 200 mg light blue triangular tablets imprinted with U U 114.*
FDA Label Image

Image (03f59daf B60e 46d1 B121 6a39361ee4f3 789 3)

FDA Label Image

Lamotrigine Tab Usp 25mg (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 04)

Lamotrigine Tab Usp 25mg (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 04)
Lamotrigine Tab. USP, 25mg tablet packaging label from Preferred Pharmaceuticals, Inc. The label includes the generic name Lamotrigine, dosage strength 25 mg, tablet form, and states it is generic for Lamictal. It features storage instructions and cautions against transferring the drug to others. The label is primarily yellow and white with English and Spanish dosing instructions."*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.